MKKOF yields 3.47% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MKKOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MKKOF + PFE for your $10,000?
Marimekko Oyj, a lifestyle design company, designs, manufactures, markets, wholesales, and retails clothing, bags and accessories, and interior decoration products worldwide. The company offers various clothes, such as dresses, tops and tunics, coats and jackets, skirts, trousers, knits, and nightwear and loungewear for women, as well as unisex and kids clothing products. It also provides leather, canvas, shoulder, and handbags, as well as backpacks, purses, and wallets. In addition, the company offers printed fabrics; kitchen and dining products, home decor products, bedding products, and bath and towel products; and accessories, including shoes, hats, scarves, socks, and umbrellas. Further, it is involved in licensing activities. As of March 21, 2022, the company operated a network of approximately 150 Marimekko stores. It also sells its products through online stores. Marimekko Oyj was founded in 1951 and is headquartered in Helsinki, Finland.
Full MKKOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.